AMY DAVIES: Open Payments
NPI 1790813285 · JACKSON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,049 in 97 payments from 25 companies in 2025. Trend: 2023 $117 · 2024 $23 · 2025 $2,049
Food & beverage: $2,006Education: $43
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 18 | $310 |
| Lilly USA, LLC | 13 | $219 |
| Tandem Diabetes Care, Inc. | 5 | $160 |
| Mannkind Corporation | 6 | $150 |
| Xeris Pharmaceuticals, Inc. | 7 | $144 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $130 |
| Medtronic, Inc. | 3 | $97 |
| Novo Nordisk Inc | 5 | $90 |
| Madrigal Pharmaceuticals | 3 | $85 |
| Neurocrine BioSciences, Inc. | 2 | $71 |
Products named: Korlym, JARDIANCE, t:slim X2 Insulin Pump with Control-IQ, AFREZZA, GVOKE HYPOPEN, MOUNJARO, MINIMED 780G, REZDIFFRA.
Industry payments across MI — which companies pay providers there.
